Cardiovascular problems in noncardiac surgery

Current Opinion in Critical Care

Volumn 15, Issue 4, 2009, Pages 333-341

  London, Martin J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Clinical Anesthesia Anesthesia ^*  (United States)

Author keywords

adrenergic blockade; Guidelines; Myocardial infarction; Natriuretic peptides; Postoperative complications; Troponins

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; TROPONIN;

BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CORONARY STENT; HEART INFARCTION; HEART PROTECTION; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREDICTION; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT; STANDARD; SURGICAL PATIENT; TIMED DRUG RELEASE;

ADRENERGIC BETA-ANTAGONISTS; CARDIOVASCULAR SYSTEM; HUMANS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; POSTOPERATIVE COMPLICATIONS; TROPONIN;

EID: 68949208450     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32832e4795     Document Type: Review

References (61)

1. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371:1839-1847.
2. Mackey WC, Fleisher LA, Haider S, et al. Perioperative myocardial ischemic injury in high-risk vascular surgery patients: incidence and clinical significance in a prospective clinical trial. J Vasc Surg 2006; 43:533-538.
3. Newsome LT, Kutcher MA, Royster RL. Coronary artery stents. Part I: Evolution of percutaneous coronary intervention. Anesth Analg 2008; 107:552-569.
4. Newsome LT, Weller RS, Gerancher JC, et al. Coronary artery stents. Part II: Perioperative considerations and management. Anesth Analg 2008; 107:570-590.
5. Hammill BG, Curtis LH, Bennett-Guerrero E, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 2008; 108:559-567.
6. Kheterpal S, O'Reilly M, Englesbe MJ, et al. Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology 2009; 110:58-66.
7. Alpert JS, Thygesen K, Jaffe A, White HD. The universal definition of myocardial infarction: a consensus document: ischaemic heart disease. Heart 2008; 94:1335-1341.
8. Apple FS, Wu AH, Jaffe AS, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. Clin Biochem 2008; 41:222-226.
9. Sabatine MS, Morrow DA, de Lemos JA, et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009; 30:162-169.
10. Fleisher LA, Beckman JA, Brown KA, etal. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation 2006; 113:2662-2674.
11. Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009; 301:831-841.
12. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:1971-1996.
13. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
14. Beattie WS, Abdelnaem E, Wijeysundera DN, Buckley DN. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigra-phy imaging. Anesth Analg 2006; 102:8-16.
15. Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress Echocardiography Expert Consensus Statement - executive summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009; 30:278-289.
16. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
17. Ward HB, Kelly RF, Thottapurathu L, et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg 2006; 82:795-800.
18. Jaroszewski DE, Huh J, Chu D, et al. Utility of detailed preoperative cardiac testing and incidence of postthoracotomy myocardial infarction. J Thorac Cardiovasc Surg 2008; 135:648-655.
19. Poldermans D, Bax JJ, Schouten O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 2006; 48:964-969.
20. Poldermans D, Hoeks SE, Feringa HH. Preoperative risk assessment and risk reduction before surgery. J Am Coll Cardiol 2008; 51:1913-1924.
21. Pace NL. Independent predictors from stepwise logistic regression may be nothing more than publishable P values. Anesth Analg 2008; 107:1775-1778.
22. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007; 49:734-739.
23. American Society of Anesthesiologists Committee on Standards and Practice Parameters. Practice alert for the perioperative management of patients with coronary artery stents: a report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2009; 110:22-23.
24. Nuttall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008; 109:588-595.
25. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109:596-604.
26. Abrahamsson B, Lucker P, Olofsson B, et al. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations. J Clin Pharmacol 1990; 30:S46-S54.
27. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341:1789-1794.
28. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996; 335:1713-1720.
29. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major noncardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006; 332:1482.
30. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97:623-633.
31. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in noncardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005; 331:313-321.
32. McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: what is the actual risk reduction? Surgery 2005; 138:171-179.
33. Schouten O, Shaw LJ, Boersma E, et al. A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coron Artery Dis 2006; 17:173-179.
34. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative {beta}-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg 2007; 104:27-41.
35. Bangalore S, Wetterslev J, Pranesh S, et al. Perioperative beta blockers in patients having noncardiac surgery: a meta-analysis. Lancet 2008;372:1962-1976.
36. Beattie WS, Wijeysundera DN, Karkouti K, et al. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 2008; 106:1039-1048.
37. Biccard BM, Sear JW, Foex P. Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. Br J Anaesth 2008; 100:23-28.
38. Fleisher LA, Poldermans D. Perioperative beta blockade: where do we go from here? Lancet 2008; 371:1813-1814.
39. Auerbach AD. Changing the practice of perioperative cardioprotection: perioperative {beta}-blockers after POISE (PeriOperative ISchemic Evaluation). Circ Cardiovasc Qual Outcomes 2008; 1:58-61.
40. London MJ. Quo vadis, perioperative beta blockade? Are you 'POISE'd' on the brink? Anesth Analg 2008; 106:1025-1030.
41. Sear JW, Giles JW, Howard-Alpe G, Foex P. Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified? Br J Anaesth 2008; 101:135-138.
42. Zaugg M, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study - a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007; 107:33-44.
43. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366:1622-1632.
44. Cesanek P, Schwann N, Wilson E, et al. The effect of beta-blocker dosing strategy on regulation of perioperative heart rate and clinical outcomes in patients undergoing vascular surgery: a randomized comparison. Ann Vasc Surg 2008; 22:643-648.
45. de Virgilio C, Yaghoubian A, Nguyen A, et al. Peripheral vascular surgery using targeted beta blockade reduces perioperative cardiac event rate. J Am Coll Surg 2009; 208:14-20.
46. Hepner DL, Correll DJ, Beckman JA, et al. Needs analysis for the development of a preoperative clinic protocol for perioperative beta-blocker therapy. J Clin Anesth 2008; 20:580-588.
47. Kaafarani HM, Atluri PV, Thornby J, Itani KM. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk. Arch Surg 2008; 143:940-944.
48. Matyal R, Mahmood F, Panzica P, et al. Sex-related differences in outcome after high-risk vascular surgery after the administration of beta-adrenergic-blocking drugs. J Cardiothorac Vasc Anesth 2008; 22:354-360.
49. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 2003; 97:634-641.
50. Biccard BM. A peri-operative statin update for noncardiac surgery. Part I: The effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (nonsurgical) patients. Anaesthesia 2008; 63:52-64.
51. Biccard BM. A peri-operative statin update for noncardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial design. Anaesthesia 2008; 63:162-171.
52. Biccard BM, Goga S, de Beurs J. Dexmedetomidine and cardiac protection for noncardiac surgery: a meta-analysis of randomised controlled trials. Anaesthesia 2008; 63:4-14.
53. London MJ. Beta blockers and alpha2 agonists for cardioprotection. Best Pract Res Clin Anaesthesiol 2008; 22:95-110.
54. Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372:807-816.
55. Thygesen K, Alpert JS, Jaffe AS, White HD. Diagnostic application of the universal definition of myocardial infarction in the intensive care unit. Curr Opin Crit Care 2008; 14:543-548.
56. Lopez-Jimenez F, Goldman L, Sacks DB, et al. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J Am Coll Cardiol 1997; 29:1241-1245.
57. Chong CP, Lam QT, Ryan JE, etal. Incidence of postoperative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients. Age Ageing 2009; 38:168-174.
58. McFalls EO, Ward HB, Moritz TE, et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. Eur Heart J 2008; 29:394-401.
59. Rodseth RN, Padayachee L, Biccard BM. A meta-analysis of the utility of preoperative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008; 63:1226-1233.
60. Rajagopalan S, Croal BL, Bachoo P, et al. N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery. J Vasc Surg 2008; 48:912-917.
61. Schouten O, Hoeks SE, Goei D, etal. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. J Vasc Surg 2009; 49:435-441.